An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)
Clinical trial NCT05477524 · COMPLETED
Trial details
- NCT number
- NCT05477524
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-04
- Primary completion
- 2026-01-07
- Enrollment
- 12546
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.